1 June 2011 in Otology & Neurotology
To describe a case of cochlear nerve deficiency (CND) with unique otologic findings. A 6-year-old girl. Magnetic resonance imaging, pure tone audiometry, distortion product otoacoustic emissions, and auditory brainstem response. The patient showed moderate sensorineural hearing impairment limited to high frequency in the right ear on pure tone audiometry. The auditory brainstem response was absent on the right; however, distortion product otoacoustic emissions were detected on both sides. The right cochlear nerve at the level of the fundus was absent on 3-dimensional constructive interference in steady state magnetic resonance imaging. Most cases of CND show deafness or profound hearing loss, but the patient in this case had only moderate hearing loss. This finding provides evidence that auditory thresholds are variable in patients with CND. Therefore, careful evaluation is needed in diagnosis of patients with hearing loss.
1 December 2015 in Auris Nasus Larynx
1 January 2008 in Practica Oto-Rhino-Laryngologica
A case of laryngeal hemangioma is reported. On esophagogastroduodenoscopy, a 67-year-old man demonstrated a dark red mass in the larynx and was referred to our clinic. Fiberscopic examination showed the presence of laryngeal hemangioma in the left false vocal cord extending to the piriform sinus. CT and MRI findings were compatible with those of laryngeal hemangioma; however, the feeding artery was not detected by angiography. After performing tracheostomy under local anesthesia in order to secure the airway and obtain a good surgical field, the tumor was vaporized with CO2 laser under laryngo-micro-surgery and injected with 5% ethanolamine oleate, a sclerosing agent which has been used endoscopically in the treatment of esophageal varicus. One day after the surgery, a severe edema in the larynx was observed. However, the tumor size gradually reduced day by day and was localized in the left arytenoid three weeks after surgery.
1 January 2000 in Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology)
31 July 2023 in Auris Nasus Larynx
20 May 2023 in Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)
2-メタクリロイルオキシエチルホスホリルコリンポリマー (MPCP) の含嗽薬としての有用性を評価するため, その製剤の一つである MPCP37 の上皮細胞への細菌付着抑制作用, 保湿作用, 抗炎症作用を検討した. まず, 培養咽頭上皮細胞を MPCP37 で処理したのちに肺炎球菌を添加し, 上皮細胞への付着細菌数を測定した. さらに, 15名の健常者を対象として MPCP37 および市販されている各種含嗽薬で含嗽を行い, その3時間後の頬粘膜擦過上皮細胞への付着細菌数を測定した. 保湿作用は, MPCP37 および各種含嗽薬で含嗽したあとにペーパータオルで舌表面の水分を吸収し, その前後での舌表面の乾燥状態を口腔水分計で計測し, 両者の差を比較し評価した. 抗炎症作用は, 培養咽頭癌上皮細胞を MPCP37 および各種含嗽薬で処理したのちに Pam3CSK4 で刺激し, 培養液中の IL-8 の値を測定し評価した. その結果, MPCP37 の前処理および含嗽によって上皮細胞への付着細菌数が有意に減少し, 0.05%溶液でも細菌付着の抑制作用が認められた. また, 舌表面水分量の変化は MPCP37 含嗽群で有意に少なく, 上皮細胞の IL-8 産生量は MPCP37 の前処理によって有意に減少した. これらの結果から, MPCP37 は細菌付着抑制作用に加えて保湿作用さらに抗炎症作用を有し, 新たな含嗽薬として応用できる製剤であることが示唆された.